drugset / Trial / NCT02287259
Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)
RandomizedParallel-groupOpen-labelTreatment
Summary
Determine the efficacy and tolerability of olanzapine for treatment of acute depression in patients with bipolar II or bipolar disorder NOS compared with lithium.
Timeline
- Start
- 2014-11
- Primary completion
- 2019-03-31
- Completion
- 2019-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lithium | Unknown | 400 mg | Oral |
| Subject | Olanzapine | Small molecule | 2.5 mg | Oral |